Menu

Deep Brain Stimulation Boosts Insulin Sensitivity

One patient with diabetes was able to reduce his medication use while receiving targeted electrical pulses.

May 24, 2018
Shawna Williams

WIKIMEDIA, CRAIG HACKING AND A. PROF FRANK GAILLARDElectrical stimulation of the brain’s ventral striatum increases the body’s sensitivity to insulin, apparently by boosting dopamine levels, researchers reported yesterday (May 23) in Science Translational Medicine.

As Science reports, the finding began serendipitously, when a Dutch man being treated for obsessive-compulsive disorder with deep brain stimulation (DBS) found that his diabetes symptoms also improved. A team of researchers, most of them based at the Academic Medical Center in the Netherlands, recruited him and 14 other patients already using DBS in the same brain region via surgically implanted electrodes. The investigators discovered that the participants’ insulin sensitivity was higher when their brain-zapping devices had been on for 17 hours than when they had been off for the same period of time.

See “Tuning the Brain

Previous studies had hinted that dopamine levels in the ventral striatum play a role in insulin sensitivity, and that DBS increases those levels. To find out whether the dopamine changes might explain DBS’s effect on insulin sensitivity, the research team recruited healthy men and gave them a dopamine-depleting drug. This reduced the ability of the men’s muscles to take up glucose, an indication of insulin insensitivity.

Nima Saeidi, who studies metabolic disorders at Harvard Medical School and was not involved in the study, tells Science that DBS may not turn out to be an effective treatment for diabetes, because the disease alters the function of cells and organs over time. “It is very possible that the results the authors described here are not translatable to diabetic patients,” he says.

See “Deep Brain Stimulation Affects the Activity of Hundreds of Genes

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.